Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Randy Swan
Institution:
Candel Therapeutics (United States)
Observed institution:
Candel Therapeutics (United States)
OpenAlex ID:
A5113033872
653 Neoadjuvant CAN-2409+Prodrug plus chemoradiation for borderline resectable or locally advanced non-metastatic pancreatic adenocarcinoma (PDAC)
2023
·
W Garrett Nichols
, Mark Bloomston
, et al.
·
Regular and Young Investigator Award Abstracts
·
3
PDF
CAN-2409 plus prodrug with standard of care immune checkpoint inhibitor for patients with stage III/IV NSCLC.
2023
·
Charu Aggarwal
, Daniel Sterman
, et al.
·
Journal of Clinical Oncology
·
2
PDF
Show more works
View as search
Works count:
2
Citation count:
5
H-index:
2
I10-index:
Year
Topic
Type